Amelioration of experimental autoimmune encephalomyelitis by BLyS autovaccine.

scientific article published on 7 April 2008

Amelioration of experimental autoimmune encephalomyelitis by BLyS autovaccine. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2008.03.043
P698PubMed publication ID18440104

P50authorXiaochang XueQ59564324
P2093author name stringMeng Li
Yan Liu
Zhen Yan
Zhen Zhang
Wei Han
Cun Zhang
Yingqi Zhang
Changli Jiang
Shouzhen Wu
Weihua Wang
Wenhua Zhu
Xin Qin
Yanjie You
Yonggang Ran
Guodong Feng
P2860cites workBAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphomaQ24646563
Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatmentQ30652630
Mimotope vaccination for epitope-specific induction of anti-CD20 antibodiesQ33248515
Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosusQ33928629
Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.Q33951524
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndromeQ34108411
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelinesQ35861182
The B cell response in multiple sclerosisQ36474316
The neurobiology of multiple sclerosis: genes, inflammation, and neurodegenerationQ36610350
Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.Q44021488
Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like diseaseQ44757991
A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responsesQ45302161
Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosisQ46356205
Production and purification of recombinant human BLyS mutant from inclusion bodiesQ46484061
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.Q48200750
Behavioral testing strategies in a localized animal model of multiple sclerosis.Q48533239
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.Q51027456
An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent PathwayQ57230082
Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchangeQ61709608
Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis ratQ71710126
Therapeutic antibodies elicited by immunization against TNF-alphaQ77995733
P433issue23
P407language of work or nameEnglishQ1860
P921main subjectexperimental autoimmune encephalomyelitisQ494066
P1104number of pages9
P304page(s)2873-2881
P577publication date2008-04-07
P1433published inVaccineQ7907941
P1476titleAmelioration of experimental autoimmune encephalomyelitis by BLyS autovaccine
P478volume26

Reverse relations

cites work (P2860)
Q55428003A Single Codon Optimization Enhances Recombinant Human TNF-α Vaccine Expression in Escherichia coli.
Q38096300Challenges in the research and development of new human vaccines.
Q89509904Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
Q42107547Therapeutic effects of PADRE-BAFF autovaccine on rat adjuvant arthritis.

Search more.